Activists in Michigan File Psychedelic Legalization Voter

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
337
Activists in Michigan File Psychedelic Legalization Voter Initiative

Activists in the state of Michigan have filed a ballot measure that will legalize the possession, cultivation and sharing of psychedelic substances as well as establish a system for the spiritual and therapeutic use of psychedelics, if approved. The Students for Sensible Drug Policy, a youth-led organization, and the Michigan Chapter of Decriminalize Nature worked together on this effort. The state’s ballot initiative would legalize various entheogenic substances, including DMT, peyote, mescaline, ibogaine, psilocin and psilocybin, for individuals aged 18 and above.

During a recent interview, codirector of Decriminalize Nature Michigan Myc Williams stated that the two groups were excited to have filed the initiative and looked forward to receiving approval from the State Board of Canvassers. The measure would permit the therapeutic, guidance, supervision, counseling, spiritual, harm reduction and related supportive services with or without remuneration.

It would also authorize entities designated by a psychiatric hospital or a medical hospital that have a “certificate of need” from the Department of Health and Human Services in the state to grow and sell psychedelic substances to individuals who have a written recommendation from their physicians. In addition to legalizing psychedelics, the initiative also proposes that some drug statutes be amended in order to decrease criminal penalties for the possession of any other controlled substances categorized under Schedule I or II of Michigan law. The measure would also protect individuals from being prosecuted for “unusable, residual or minuscule” amounts of drugs found on paraphernalia and remove testing equipment that determines the purity and potency of drugs.

Executive director of the Students for Sensible Drug Policy Jason Ortiz stated in an interview that the group was proud to have advocated for a policy that would decrease the criminalization of individuals who use drugs.

The activists plan to refile their initiative soon, as the deadline to submit explanatory material and/or proposed summary language to the Board of State Canvassers is February 8. This isn’t the first time activists in the state of Michigan advanced psychedelic reform measures. Late last year, the city council of Ann Arbor made the enforcement of laws that prohibit psychedelics such as DMT, ayahuasca and psilocybin among its lowest priorities. In November, voters in Detroit also approved a ballot measure to decriminalize psychedelic substances. Earlier in September, the city council of Grand Rapids also approved a measure that supported the decriminalization of a range of psychedelics.

In the same month, two state senators also introduced a measure to legalize the possession, growing and delivery of fungi- and plant-derived psychedelics, including mescaline and psilocybin.

This wave of psychedelic policy reform is likely to have a beneficial effect upon the valuations of sector companies such as Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF), especially when they come up with breakthrough remedies that treat conditions that have been hard to treat using existing medicines.

NOTE TO INVESTORS: The latest news and updates relating to Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) are available in the company’s newsroom at https://ibn.fm/MYCOF

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer




Mydecine Innovations Group Inc (MYCOF) Stock Research Links

MYCOF Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

iCapital Enhances Portfolio Solutions For Global Investors

Updated Category News Views 267

iCapital Enhances Portfolio Construction Tools for Investors iCapital, a leading global fintech platform, has introduced significant enhancements to its innovative portfolio construction tool, iCapital Architect. This advanced platform is designed to simplify the integration of alternative investments into traditional portfolio strategies. Financial advisors gain access...

Continue Reading
Market Adaptability: S&P 500 Faces Correction Ahead

Updated Category News Views 210

Understanding Recent Market Movements The market experienced a turbulent session recently, sending investors into a state of caution. This volatility was significantly influenced by renewed discussions around tariffs impacting trade relationships, particularly involving technology and manufacturing sectors. The Impact of Tariffs on the Market Former President Trump's...

Continue Reading
Performance Systems Integration Merges with Summit Fire & Security

Updated Category News Views 177

Performance Systems Integration Merger with Summit Fire & Security Performance Systems Integration (PSI), recognized as the leading fire and life safety solutions provider in the Pacific Northwest, has completed a merger with Summit Fire & Security LLC, which is a subsidiary of SFP Holding, Inc. This merger marks a significant collaboration that aims to enhance the safety...

Continue Reading
Candel Therapeutics Shares Optimistic Findings on CAN-3110

Updated Category News Views 159

Revealing Interim Results from Candel Therapeutics NEEDHAM, Mass. — Candel Therapeutics, Inc. (Nasdaq: CADL), a biopharmaceutical company dedicated to advancing biological immunotherapies to combat cancer, has announced noteworthy interim data stemming from its ongoing phase 1b clinical trial of CAN-3110 (linoserpaturev) targeting recurrent glioblastoma. This...

Continue Reading
Supernus Pharmaceuticals Reaches New Heights with Strong Growth

Updated Category News Views 83

Supernus Pharmaceuticals Hits Record Stock Levels Supernus Pharmaceuticals Inc (NASDAQ: SUPN) has achieved a remarkable milestone, as its stock recently surged to a 52-week high of $35.45. This significant increase showcases the company’s strong financial performance and growth prospects, creating a wave of optimism among investors. The stock has risen an impressive...

Continue Reading